dc.contributor.author | Grunebaum, Amos | |
dc.contributor.author | Kusuda, Satoshi | |
dc.contributor.author | Serra, Bernat | |
dc.contributor.author | Luna, Manuel Sanchez | |
dc.contributor.author | Huertas, Erasmo | |
dc.contributor.author | Volpe, Nicola | |
dc.contributor.author | Ayala, Rodrigo | |
dc.contributor.author | Jekova, Nelly | |
dc.contributor.author | Tsakiridis, Ioannis | |
dc.contributor.author | Villalain, Cecilia | |
dc.contributor.author | Allegaert, Karel | |
dc.contributor.author | Wellmann, Sven | |
dc.contributor.author | Stanojevic, Milan | |
dc.contributor.author | Dagklis, Themistoklis | |
dc.contributor.author | Sen, Cihat | |
dc.date.accessioned | 2022-07-04T13:28:49Z | |
dc.date.available | 2022-07-04T13:28:49Z | |
dc.identifier.citation | Dagklis T., Sen C., Tsakiridis I., Villalain C., Allegaert K., Wellmann S., Kusuda S., Serra B., Luna M. S. , Huertas E., et al., "The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation", JOURNAL OF PERINATAL MEDICINE, 2022 | |
dc.identifier.issn | 0300-5577 | |
dc.identifier.other | av_4b61c159-2f00-42ed-8080-e70660a85891 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/182640 | |
dc.identifier.uri | https://avesis.istanbul.edu.tr/api/publication/4b61c159-2f00-42ed-8080-e70660a85891/file | |
dc.identifier.uri | https://doi.org/10.1515/jpm-2022-0066 | |
dc.description.abstract | This practice guideline follows the mission of the World Association of Perinatal Medicine in collaboration with the Perinatal Medicine Foundation, bringing together groups and individuals throughout the world, with the goal of improving the use of antenatal corticosteroids (ACS) for fetal maturation. In fact, this document provides further guidance for healthcare practitioners on the appropriate use of ACS with the aim to increase the timely administration and avoid unnecessary or excessive use. Therefore, it is not intended to establish a legal standard of care. This document is based on consensus among perinatal experts throughout the world and serves as a guideline for use in clinical practice. | |
dc.language.iso | eng | |
dc.subject | Cerrahi Tıp Bilimleri | |
dc.subject | Kadın Hastalıkları ve Doğum | |
dc.subject | Pediatrics | |
dc.subject | Obstetrics and Gynecology | |
dc.subject | Pediatrics, Perinatology and Child Health | |
dc.subject | Health Sciences | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Çocuk Sağlığı ve Hastalıkları | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KADIN HASTALIKLARI & DOĞUM | |
dc.subject | PEDİATRİ | |
dc.title | The use of antenatal corticosteroids for fetal maturation: clinical practice guideline by the WAPM-World Association of Perinatal Medicine and the PMF-Perinatal Medicine foundation | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF PERINATAL MEDICINE | |
dc.contributor.department | Aristotle University of Thessaloniki , , | |
dc.contributor.firstauthorID | 3402000 | |